Results 211 to 220 of about 14,439 (224)
Some of the next articles are maybe not open access.

Clinical and Regulatory Concerns of Biosimilars: A Review of Literature

International Journal of Environmental Research and Public Health, 2020
Vesa Halimi   +2 more
exaly  

Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease

Lancet, The, 2017
Giorgio Saracco   +2 more
exaly  

Knowledge and Use of Biosimilars in Oncology: A Survey by the European Society for Medical Oncology

ESMO Open, 2019
Josep Tabernero Caturla   +2 more
exaly  

Changes in Inflammatory Bowel Disease Patients’ Perspectives on Biosimilars: A Follow-Up Survey

United European Gastroenterology Journal, 2019
Silvio Danese, Laurent Peyrin-Biroulet
exaly  

Epoetin Biosimilars in Europe: Five Years On

Advances in Therapy, 2013
Ashraf Mikhail
exaly  

Comparing Originator Biologics and Biosimilars: A Review of the Relevant Issues

Clinical Therapeutics, 2017
Corrado Blandizzi   +2 more
exaly  

Biosimilars: What the Oncologist Should Know

Future Oncology, 2019
Gary Lyman, Marc Thill, Vladimir Hanes
exaly  

The Nocebo Effect: A Clinical Challenge in the Era of Biosimilars

Expert Review of Clinical Immunology, 2018
Silvio Danese   +2 more
exaly  

Biosimilars: How Similar are They?

The International Journal of Artificial Organs, 2005
openaire   +3 more sources

Home - About - Disclaimer - Privacy